The Latest

Total Knee Arthroplasty (TKA) is a life-changing intervention for patients with end-stage knee osteoarthritis. With over 600,000 procedures performed annually in the U.S. — and projected to rise nearly sevenfold by 2030—its impact is profound. Yet, despite the success of conventional techniques, up to a quarter of patients remain dissatisfied, often due to the inability to fully replicate the natural motion of the knee.The emergence of Robotic-Assisted TKA (RA-TKA) promises unprecedented precision in implant placement and alignment, with the aim of improving patient satisfaction and long-term implant survivorship. But the technology’s adoption is slowed by unresolved debates, inconsistent outcomes data, and the high financial burden of robotic systems. The orthopedic community continues to grapple with critical questions:Does RA-TKA truly deliver superior patient-perceived benefits in the long term?Is kinematic alignment (KA) better than mechanical alignment (MA)?Can the costs and learning curve be justified by measurable improvements in outcomes?Randomized Controlled Trials (RCTs) are the gold standard for evaluating surgical interventions, but they have limitations in real-world applicability due to controlled environments and narrow patient selection. Real-World Evidence (RWE) fills this gap, capturing data from routine clinical practice.However, traditional “big data” RWE sources — derived from EMRs, registries, and insurance claims — are often incomplete, unverifiable, and lack the longitudinal follow-up needed for meaningful conclusions. These shortcomings hinder the ability to answer pressing RA-TKA questions, particularly around alignment strategies, implant longevity, and cost-effectiveness.RegenMed’s Circles platform is engineered to address these evidence gaps with a methodology that mirrors the rigor of clinical trials while maintaining the practicality of real-world data collection.Key Features:Direct, Verifiable Data Sourcing: Information comes straight from physicians, patients, and laboratories, each datapoint time-stamped and immutable.Longitudinal Case Tracking: Every dataset follows a complete patient journey, from enrollment through long-term outcomes, capturing critical measures like implant survivorship and patient satisfaction.Driven Relevance: Each dataset is tied to a specific Observational Protocol (OP) for targeted, clinically meaningful insights—such as robotic KA vs. MA comparisons.Good Clinical Practice (GCP) Compliance: The platform inherently supports ethical and regulatory standards, including IRB processes and patient consent.Equitable Ownership and Benefits: Circle members retain data ownership and can receive up to 85% of licensing value, incentivizing participation.Solving RA-TKA’s Evidence Challenges:Quality and Verifiability: Circles eliminates the ambiguity of traditional datasets, enabling robust comparative studies of alignment strategies and robotic platforms.Long-Term Outcomes: Continuous data capture supports proactive monitoring of implant performance, complications, and evolving patient satisfaction.Cost-Effectiveness: Granular, structured data allows detailed economic analyses, critical in evaluating the true return on investment of robotic systems.Surgeon Learning Curve: Performance tracking over time can inform training programs and credentialing standards.Patient-Reported Outcomes (PROMs): High-fidelity capture ensures the patient’s voice is central in assessing surgical success.Robotic-assisted knee replacement holds tremendous promise, but the orthopedic field needs better answers before widespread adoption. Circles provides the framework to generate those answers — efficiently, cost-effectively, and with clinical rigor. By combining the precision of RA-TKA with the precision of high-quality RWE, Circles can guide technology adoption, resolve long-standing debates, and improve patient outcomes at scale.

We are pleased to announce the launch of our fundraising campaign on the Dealmaker platform. This presents a unique opportunity to invest in our company’s growth and strategic vision. We invite you to join us on this exciting journey as we strive to achieve our goals and generate lasting value together. To learn more and explore how you can become part of our story, please visit our campaign page.

Are you a podiatry specialist looking to elevate your clinical practice through data ownership, collaboration, and innovation? RegenMed proudly introduces the Shockwave Podiatry Circles — a physician-owned community designed exclusively for podiatry specialists. Led by industry experts like Nathan Ivey, Owner of New Mexico Foot & Ankle Institute, and Kurt Relation, a board-certified Podiatric Surgeon and owner of Bluestone Podiatry in Slingerlands, NY, it has already demonstrated promising results over the past 3 months. ‍Why join the Shockwave Podiatry Circle? Full ownership and governance of your clinical dataActionable clinical and financial insights to grow your practiceCollaborative opportunities within a focused, expert communityAccess to real-world evidence that advances podiatric careMark your calendar: Our upcoming Circle Hour scheduled for early October — a dedicated session to analyze the latest data and outcomes, share insights, and discuss the future of Shockwave therapy in podiatry. Interested? ‍Reach out today to learn more and secure your spot: https://www.rgnmed.com/circle-library/foot-and-ankle-plantar-fasciitis-shockwave-vas-ffi

The Power of Internally Generated EvidenceIn the quest to improve outcomes in total knee (TKA) and total hip arthroplasty (THA), Real-World Evidence (RWE) has become indispensable. However, the traditional sources of RWE — claims databases, generalized EHRs, and broad registries — often suffer from data quality issues, inconsistent definitions, and limited traceability. RegenMed’s TKA and THA Circles utilize a closed data system that captures, validates, and leverages high-quality data generated entirely within the care ecosystem. This ensures unambiguous ownership by the provider group of all data, along with its attendant clinical and financial value.Circles focus on internal validity over generalizability. Instead of aggregating disparate data sources, they efficiently capture detailed clinician entries, directly reported patient outcomes, and validated device data within a singular, controlled environment. The result is highly trusted, clinically actionable evidence that enables precise quality improvement and local innovation.Data That Drives ImprovementCircles collect a rich spectrum of data directly at the source. From granular surgical technique details and implant identifiers to validated Patient-Reported Outcome Measures (PROMs), the system ensures every data point is structured, time-stamped, and contextually relevant. Examples include:‍‍Clinician-entered details: surgical approach, anesthesia type, implant lot numbers, and intraoperative events.‍Patient-reported outcomes: pain and function scores (e.g., KOOS JR, HOOS JR), satisfaction, and health literacy, collected via tablets, portals, or mobile apps.Device integration: metrics like range of motion or activity levels from validated wearables and intraoperative sensors.Critically, all data flows through validation checkpoints — automated rules, structured forms, and internal audits — to maintain integrity. This allows for nuanced analysis of surgical techniques, implant performance, patient subgroups, and care pathways.Applications Within the SystemThe true strength of closed-system RWE lies in its targeted application. It empowers:Surgeon and site benchmarking: Enabling risk-adjusted comparisons of PROMs, complications, and revisions.Comparative effectiveness: Studying local outcomes from different implants, approaches, or protocols.Longitudinal outcome tracking: Understanding patient recovery trajectories and long-term implant performance.Personalized care: Using AI/ML models to predict outcomes, stratify risk, and inform shared decision-making based on system-specific data.Moreover, RegenMed’s TKA and THA Circles foster continuous improvement by linking outcomes to care practices. For example, PROM data can inform refinements in perioperative protocols, while validated device metrics can enhance rehabilitation pathways.Navigating Limitations with TransparencyCircles offer precision and trust — but with trade-offs. Because a single provider’s findings apply primarily to its own population and practice environment, generalizability is limited. Circles address these challenges by supporting broad participation in the same TKA or THA Observational Protocol by any type of provider – academic medical centers, independent provider groups and even sole practitioners — wherever located in the world. ConclusionRegenMed’s THA and TKA Circles represent a forward-thinking strategy to generate clinically meaningful RWE for orthopedic procedures. They are essential to genuine value-based care environments. By focusing on internal data integrity and application, they provide a blueprint for organizations seeking to enhance surgical outcomes, personalize patient care, and lead with data-driven precision—all from within their own ecosystem.

In today’s healthcare landscape, independent practices face mounting financial pressures—from reimbursement challenges to rising operational costs. Yet, amid these hurdles, innovative solutions like RegenMed are transforming how physicians can generate sustainable revenue and enhance their practice’s value — all without significant investment or added burden.Introducing RegenMed’s Physicians-Owned Circles (POCs): a game-changing, turnkey platform designed to empower clinicians to own, monetize, and leverage their real-world data efficiently and affordably.Why Choose RegenMed Circles?Minimal Upfront CostEach POC costs as little as $5 per case and $35 monthly — an accessible fee that ensures virtually no risk for your practice. This low barrier enables you to start capturing and monetizing valuable data immediately.High-Quality Data at Low CostOur patented platform streamlines data collection, requiring less than a minute per case, so your clinical workflow remains uninterrupted. The result? High-quality, statistically significant datasets developed with minimal effort.Shared Revenue and OwnershipAs a member, you own 75% of the value generated from your dataset’s licensing, royalties, and other monetization streams. Additionally, physicians retain 85% of dataset ownership, turning your clinical insights into tangible financial returns.Multiple Revenue StreamsBeyond dataset monetization, POC participation opens avenues for consulting fees, publication opportunities, and enhanced patient engagement — further diversifying your income potential and practice reputation.Long-Term Practice EquityUnlike traditional models that leave practices with only patient fees and no residual value, RegenMed’s approach builds practice equity through high-quality datasets — assets that grow in value over time and can be monetized repeatedly.Scalable and FlexibleStart with one POC or multiple — scale your data assets as your practice grows. Our study protocols are tailored to your specialty, ensuring relevance and maximum value.Discover how your practice can benefit today — visit RegenMed’s POC Library or contact us to learn more about building your practice’s data-driven revenue streams.